Sigma-Aldrich Partners with The Scripps Research Institute
Sigma-Aldrich (Missouri, USA) has announced that it has partnered with The Scripps Research Institute (TSRI) (California, USA) to speed up access to discoveries by TSRI scientists to synthesize and analyze potential drugs. The partnership is the first to be formed between an academic institution and a reagents company.
Sigma-Aldrich (Missouri, USA) has announced that it has partnered with The Scripps Research Institute (TSRI) (California, USA) to speed up access to discoveries by TSRI scientists to synthesize and analyze potential drugs. The partnership is the first to be formed between an academic institution and a reagents company.
Sigma-Aldrich will provide funding for research projects focused on the development of new reagents in six TRSI labs. Newly developed reagents will then be marketed exclusively by Sigma-Aldrich. Publications relating to new reagents will include a Sigma-Aldrich product number for reference.
Amanda Halford, Vice President, Academic Research at Sigma-Aldrich said: “The hurdles from bench to clinic, what the National Institute of Health (NIH) calls the 'valley of death', are proving difficult to surmount, leaving numbers of potential therapeutic ideas trapped inside university doors.” She added: “To clear these hurdles, it's critical to open a myriad of novel technologies, such as these from TSRI, to the whole translational research community.”
For more information please visit:
www.sigma-aldrich.com
or
www.scripps.edu
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
Liquid Chromatography to Analyze Vitamin D Proteins in Psoriasis Patients
January 21st 2025Can a protein involved in delivering Vitamin D to target tissues have an altered serum profile in psoriasis patients with cardiovascular disease? Researchers used liquid chromatography (LC) to help find out.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
